85 related articles for article (PubMed ID: 20529331)
21. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review.
Soy M; Keser G; Atagunduz P; Mutlu MY; Gunduz A; Koybaşi G; Bes C
Clin Rheumatol; 2021 Sep; 40(9):3533-3545. PubMed ID: 33751280
[TBL] [Abstract][Full Text] [Related]
22. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
Curtis JR; Johnson SR; Anthony DD; Arasaratnam RJ; Baden LR; Bass AR; Calabrese C; Gravallese EM; Harpaz R; Sadun RE; Turner AS; Williams EA; Mikuls TR
Arthritis Rheumatol; 2021 Jul; 73(7):1093-1107. PubMed ID: 33728796
[TBL] [Abstract][Full Text] [Related]
23. Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.
Beecker J; Papp KA; Dutz J; Vender RB; Gniadecki R; Cooper C; Gisondi P; Gooderham M; Hong CH; Kirchhof MG; Lynde CW; Maari C; Poulin Y; Puig L
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):797-806. PubMed ID: 33533553
[TBL] [Abstract][Full Text] [Related]
24. An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.
Gresham LM; Marzario B; Dutz J; Kirchhof MG
J Am Acad Dermatol; 2021 Jun; 84(6):1652-1666. PubMed ID: 33482251
[TBL] [Abstract][Full Text] [Related]
25. Immune Monitoring upon Treatment with Biologics in Sjögren's Syndrome: The What, Where, When, and How.
van Beers JJBC; Damoiseaux JGMC
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33467204
[TBL] [Abstract][Full Text] [Related]
26. Vaccinology Education of Nurses and the Current Immunoprophylaxis Recommendations for Children with Juvenile Idiopathic Arthritis.
Bednarek A; Klepacz R
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233818
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.
Rondaan C; Furer V; Heijstek MW; Agmon-Levin N; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; Ladefoged de Thurah A; Landewé R; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; van Assen S; Elkayam O
RMD Open; 2019; 5(2):e001035. PubMed ID: 31565247
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive review of rituximab therapy in rheumatoid arthritis patients.
Tavakolpour S; Alesaeidi S; Darvishi M; GhasemiAdl M; Darabi-Monadi S; Akhlaghdoust M; Elikaei Behjati S; Jafarieh A
Clin Rheumatol; 2019 Nov; 38(11):2977-2994. PubMed ID: 31367943
[TBL] [Abstract][Full Text] [Related]
29. Current perspective on rituximab in rheumatic diseases.
Schioppo T; Ingegnoli F
Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
[TBL] [Abstract][Full Text] [Related]
30. [Immunization in children and adolescents with rheumatic and musculoskeletal diseases].
Minden K; Speth F; Huppertz HI; Borte M
Z Rheumatol; 2014 Dec; 73(10):878-89. PubMed ID: 25479932
[TBL] [Abstract][Full Text] [Related]
31. Vaccinations for rheumatoid arthritis.
Perry LM; Winthrop KL; Curtis JR
Curr Rheumatol Rep; 2014 Aug; 16(8):431. PubMed ID: 24925587
[TBL] [Abstract][Full Text] [Related]
32. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
Westra J; van Assen S; Wilting KR; Land J; Horst G; de Haan A; Bijl M
Clin Exp Immunol; 2014 Oct; 178(1):40-7. PubMed ID: 24889761
[TBL] [Abstract][Full Text] [Related]
33. Rituximab for the treatment of rheumatoid arthritis: an update.
Mok CC
Drug Des Devel Ther; 2013 Dec; 8():87-100. PubMed ID: 24403823
[TBL] [Abstract][Full Text] [Related]
34. [Pneumococcus vaccination in immunosuppressed patients: current recommendations].
Krause A; Krüger K
Z Rheumatol; 2013 Dec; 72(10):942-6. PubMed ID: 24221454
[No Abstract] [Full Text] [Related]
35. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia.
Nazi I; Kelton JG; Larché M; Snider DP; Heddle NM; Crowther MA; Cook RJ; Tinmouth AT; Mangel J; Arnold DM
Blood; 2013 Sep; 122(11):1946-53. PubMed ID: 23851398
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.
Brisslert M; Rehnberg M; Bokarewa MI
Immunology; 2013 Dec; 140(4):421-9. PubMed ID: 23844744
[TBL] [Abstract][Full Text] [Related]
37. B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.
Leandro MJ
Arthritis Res Ther; 2013; 15 Suppl 1(Suppl 1):S3. PubMed ID: 23566754
[TBL] [Abstract][Full Text] [Related]
38. Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity.
Mei HE; Schmidt S; Dörner T
Arthritis Res Ther; 2012; 14 Suppl 5(Suppl 5):S1. PubMed ID: 23281743
[TBL] [Abstract][Full Text] [Related]
39. Pediatric rheumatic disease: Vaccination in pediatric rheumatic disease--risks and benefits.
Janow G; Ilowite NT
Nat Rev Rheumatol; 2012 Feb; 8(4):188-90. PubMed ID: 22331060
[No Abstract] [Full Text] [Related]
40. Vaccination against infection in patients with multiple sclerosis.
Loebermann M; Winkelmann A; Hartung HP; Hengel H; Reisinger EC; Zettl UK
Nat Rev Neurol; 2012 Jan; 8(3):143-51. PubMed ID: 22270022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
